Cardiovascular risk profiles: A cross-sectional study evaluating the generalizability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN-6 to the real-world type 2 diabetes population in the united kingdom
doi:10.1056/NEJMoa2032183 2Wilding JPH, Batterham RL, Calanna S, et al
Rare but notable risks include pancreatitis, gallbladder events, and a theoretical concern regarding thyroid C-cell tumors observed in animal studies
Begin Your Journey The help you need is just a step away
Consult Healthcare Professionals for Safe Dosing Before you start or adjust your semaglutide dosage, its crucial to consult a healthcare professional
CAPTURE: a cross-sectional study of the contemporary (2019) prevalence of cardiovascular disease in adults with type 2 diabetes in Brazil